Xingrui Li

719 total citations · 1 hit paper
26 papers, 401 citations indexed

About

Xingrui Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xingrui Li has authored 26 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Xingrui Li's work include Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Xingrui Li is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Xingrui Li collaborates with scholars based in China, France and Hong Kong. Xingrui Li's co-authors include Menglu Dong, Hanning Li, Tao Xu, Wenfei Xia, Heather Miller, Pamela Lee, Huamei Forsman, Zhimin Zhai, Kamel Benlagha and Masato Kubo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Xingrui Li

25 papers receiving 395 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The interaction of innate immune and adaptive immune system

2024 74 citations Kamel Benlagha, Niels Olsen Saraiva Câmara et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingrui Li China	12	264	143	91	91	58	26	401
Dafei Xie China	13	365 1.4×	135 0.9×	62 0.7×	119 1.3×	50 0.9×	37	492
Alexander C. Jordan United States	7	307 1.2×	87 0.6×	60 0.7×	134 1.5×	46 0.8×	10	453
Li‐Hua Yang China	15	332 1.3×	267 1.9×	78 0.9×	123 1.4×	89 1.5×	33	524
Rongjun Cui China	13	309 1.2×	229 1.6×	55 0.6×	108 1.2×	54 0.9×	27	440
Nicola Inzerilli Italy	5	302 1.1×	120 0.8×	77 0.8×	99 1.1×	30 0.5×	8	420
Małgorzata Krześniak Poland	11	237 0.9×	89 0.6×	35 0.4×	108 1.2×	40 0.7×	23	325
Guoyin Li China	13	343 1.3×	230 1.6×	111 1.2×	156 1.7×	56 1.0×	35	584
Maryann Mikhail United States	9	158 0.6×	94 0.7×	102 1.1×	140 1.5×	52 0.9×	16	365
Ori Hassin Israel	6	307 1.2×	136 1.0×	75 0.8×	264 2.9×	65 1.1×	8	522

Countries citing papers authored by Xingrui Li

Since Specialization

Citations

This map shows the geographic impact of Xingrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingrui Li more than expected).

Fields of papers citing papers by Xingrui Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingrui Li. The network helps show where Xingrui Li may publish in the future.

Co-authorship network of co-authors of Xingrui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xingrui Li. A scholar is included among the top collaborators of Xingrui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingrui Li. Xingrui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yulin, et al.. (2025). Fusion model integrating multi-sequence MRI radiomics and habitat imaging for predicting pathological complete response in breast cancer treated with neoadjuvant therapy. Cancer Imaging. 25(1). 108–108. 2 indexed citations

Tang, Jingwei, Xingrui Li, R. Mai, et al.. (2025). Application and Prospects of Smart Dressings in Wound Healing. ACS Applied Materials & Interfaces. 17(40). 55808–55832. 1 indexed citations

Mai, R., Yongsheng Zhou, Kangning Zhao, et al.. (2025). Biosensors based on organic transistors for intraoral biomarker detection. Microchimica Acta. 192(6). 335–335. 1 indexed citations

Jiang, Yixuan, et al.. (2025). Smart stimuli-responsive biomaterials for oral and maxillofacial tissue repair and regeneration. Chemical Engineering Journal. 524. 168339–168339.

Zhang, Qingyuan, Zhonghua Wang, Simon Li, et al.. (2024). A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer. BMC Cancer. 24(1). 1143–1143. 3 indexed citations

Li, Hanning, Wenfei Xia, Teng Cheng, et al.. (2024). Long-term survival in a patient with metastatic parathyroid carcinoma harboring an EGFR sensitizing mutation: a case report. Journal of International Medical Research. 52(7). 3649320597–3649320597. 1 indexed citations

Benlagha, Kamel, Niels Olsen Saraiva Câmara, Heather Miller, et al.. (2024). The interaction of innate immune and adaptive immune system. SHILAP Revista de lepidopterología. 5(10). e714–e714. 74 indexed citations breakdown →

Cui, Xiaoqing, et al.. (2024). HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer. Molecular Carcinogenesis. 63(9). 1800–1813. 8 indexed citations

Dai, Zhou‐Tong, et al.. (2023). MKL-1 suppresses ferroptosis by activating system Xc- and increasing glutathione synthesis. International Journal of Biological Sciences. 19(14). 4457–4475. 3 indexed citations

10.

Li, Shuyu, Nan Zhang, Hao Zhang, et al.. (2022). ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas. Frontiers in Oncology. 12. 844144–844144. 33 indexed citations

11.

Dong, Menglu, et al.. (2022). Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 785058–785058. 10 indexed citations

12.

Dong, Menglu, et al.. (2022). Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer. Aging. 14(13). 5427–5448. 9 indexed citations

13.

Dong, Menglu, et al.. (2021). NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer. Oncology Letters. 21(4). 323–323. 18 indexed citations

14.

Zhang, Jinjin, Xiangyi Ma, Ronghua Liu, et al.. (2020). Metformin intervention against ovarian toxicity during chemotherapy for early breast cancer: Study protocol for a randomized double-blind placebo-controlled trial. Maturitas. 137. 1–6. 4 indexed citations

15.

Huang, Yajing, Hao Wu, & Xingrui Li. (2020). Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer. Cancer Cell International. 20(1). 501–501. 15 indexed citations

16.

Xu, Tao, Menglu Dong, Zhi Wang, Hanning Li, & Xingrui Li. (2020). <p>Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer</p>. Cancer Management and Research. Volume 12. 5773–5786. 17 indexed citations

17.

Li, Hanning, et al.. (2020). Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high‐level immune infiltration status. Cancer Medicine. 9(24). 9554–9570. 19 indexed citations

18.

Xu, Tao, Rui Zhang, Menglu Dong, et al.. (2019). <p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>. OncoTargets and Therapy. Volume 12. 10639–10650. 43 indexed citations

19.

Xia, Wenfei, et al.. (2015). miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail. Oncology Reports. 34(2). 655–662. 40 indexed citations

20.

Zhu, Zhi, et al.. (2012). Endothelial progenitor cells homing to the orthotopic implanted liver tumor of nude mice. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(5). 675–679. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact